Nitric oxide as a mediator of reduced arterial responsiveness in septic patients

Critical Care Medicine

Volumn 24, Issue 6, 1996, Pages 1083-1086

  Tsuneyoshi, Isao ^a   Kanmura, Yuichi ^a   Yoshimura, Nozumu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

critical illness; human artery; hypotension; methylene blue; N(G) nitro L arginine methyl ester; nitric oxide; nitric oxide synthase; sepsis; septic shock; vascular resistance

Indexed keywords

ADRENALIN; ARGININE; DOBUTAMINE; DOPAMINE; HYPERTENSIVE AGENT; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MESENTERIC ARTERY; OMENTUM; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE;

AGED; ARGININE; ENZYME INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPOTENSION; MESENTERIC ARTERIES; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NOREPINEPHRINE; SHOCK, SEPTIC; VASOCONSTRICTION;

EID: 0029973006     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199606000-00033     Document Type: Article

References (18)

1. Schmidt HHHW, Walter U: NO at work. Cell 1994; 78:919-925
2. Radmski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990; 87:10043-10047
3. Beasley D: Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol 1990; 259:R38-R44
4. Joulou-Schaeffer G, Gray G, Fleming I: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259: H1038-H1043
5. Ignarro LJ: Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65:1-21
6. Ochoa JB, Udekwu AO, Billar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626
7. Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with sepsis syndrome. Circ Shock 1993; 41:77-81
8. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558
9. Geroulanos S, Schilling J, Cakmakci M, et al: Inhibition of NO synthesis in septic shock. Lancet 1992; 339:434-435
10. Lorente J, Landin L, Pablo RD, et al: L-arginine pathway in sepsis syndrome. Crit Care Med 1993; 21:1287-1295
11. Lowry SF: Sepsis and complications: Clinical definitions and therapeutic prospects. Crit Care Med 1994; 22:S1-S2
12. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidances for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
13. Gómez-Jiménez J, Salgado A, Mourello M, et al: L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23: 253-258
14. G-monomethyl-L-arginine on endotoxin-induced alterations of vascular reactivity. Life Sci 1991; 48: 189-193
15. Preiser T-C, Lejeune P, Roman A, et al: Methylene blue administration in septic shock: A clinical trial. Crit Care Med 1995; 23:259-264
16. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142
17. Scott-Burden T, Schini VB, Elizondo E, et al: Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Circles 1992; 71:1088-1100
18. Berrazueta JR, Amado ESJ, Vega MJS, et al: Induction of nitric oxide synthase in human mammary arteries in vitro. Eur J Pharmacol 1994; 251:303-305